Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years
- PMID: 4537478
- PMCID: PMC2480706
Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years
Abstract
This study was undertaken in 1968 in collaboration with the World Health Organization as part of a co-operative evaluation of vaccination programmes. The situation in Sweden was of particular interest as only inactivated vaccines had been used for immunization against poliomyelitis. The WHO programme includes evaluation of both seroimmunity and resistance to poliovirus infection but the present report concerns only the serological studies.About 3 000 people, selected on a statistical basis as being a representative sample of the Swedish population, were sent questionnaires concerning their vaccinations against poliomyelitis. Answers were returned by 90% of the sample population and blood samples were collected from 2 294 persons. More than 95% of subjects under 30 years of age had received 2 or more injections, but the proportion of vaccinated individuals decreased slightly among people over 30 years of age. In the oldest age group questioned (60-70 years) only 20% had been vaccinated. Antibodies to the 3 types of poliovirus were present in more than 95% of the sera in all age groups except two. Samples seronegative to one or more types of virus were found in about 15% of people in the oldest age group and among children vaccinated during the first years of poliovirus vaccination (1957-61).
Similar articles
-
[Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].Ned Tijdschr Geneeskd. 1993 Jul 10;137(28):1380-6. Ned Tijdschr Geneeskd. 1993. PMID: 8240513 Review. Dutch.
-
Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.Ann Clin Lab Sci. 1994 Nov-Dec;24(6):542-7. Ann Clin Lab Sci. 1994. PMID: 7847782
-
Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.Can Med Assoc J. 1975 Oct 4;113(7):619-23. Can Med Assoc J. 1975. PMID: 1181016 Free PMC article.
-
Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.Dev Biol Stand. 1981;47:257-9. Dev Biol Stand. 1981. PMID: 7227654
-
[Current perspectives in virology: prevention].Immun Infekt. 1993 Dec;21(6):177-9. Immun Infekt. 1993. PMID: 8144183 Review. German.
Cited by
-
Wanted, dead or alive: new viral vaccines.Antiviral Res. 2009 Nov;84(2):119-30. doi: 10.1016/j.antiviral.2009.08.008. Epub 2009 Sep 4. Antiviral Res. 2009. PMID: 19733596 Free PMC article. Review.
-
Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes.Bull World Health Organ. 1982;60(3):405-22. Bull World Health Organ. 1982. PMID: 6814774 Free PMC article.
-
Is EU/EEA population protected from polio?Hum Vaccin Immunother. 2015;11(9):2123-31. doi: 10.1080/21645515.2015.1016673. Epub 2015 Apr 21. Hum Vaccin Immunother. 2015. PMID: 25898095 Free PMC article.
-
Inactivated polio vaccine: its proposed role in the final stages of polio eradication.Pan Afr Med J. 2013 Mar 13;14:102. doi: 10.11604/pamj.2013.14.102.2580. Print 2013. Pan Afr Med J. 2013. PMID: 23717717 Free PMC article. No abstract available.
-
Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.Epidemiol Infect. 1988 Dec;101(3):605-9. doi: 10.1017/s0950268800029472. Epidemiol Infect. 1988. PMID: 2850939 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources